509 related articles for article (PubMed ID: 33601007)
1. In vitro activity of ibrexafungerp and comparators against Candida albicans genotypes from vaginal samples and blood cultures.
Mesquida A; Vicente T; Reigadas E; Palomo M; Sánchez-Carrillo C; Muñoz P; Guinea J; Escribano P
Clin Microbiol Infect; 2021 Jun; 27(6):915.e5-915.e8. PubMed ID: 33601007
[TBL] [Abstract][Full Text] [Related]
2. In vitro activity of ibrexafungerp against Candida species isolated from blood cultures. Determination of wild-type populations using the EUCAST method.
Mesquida A; Díaz-García J; Sánchez-Carrillo C; Muñoz P; Escribano P; Guinea J
Clin Microbiol Infect; 2022 Jan; 28(1):140.e1-140.e4. PubMed ID: 34619396
[TBL] [Abstract][Full Text] [Related]
3.
Arendrup MC; Jørgensen KM; Hare RK; Chowdhary A
Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31844005
[TBL] [Abstract][Full Text] [Related]
4. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
5.
Quindós G; Miranda-Cadena K; San-Millán R; Borroto-Esoda K; Cantón E; Linares-Sicilia MJ; Hamprecht A; Montesinos I; Tortorano AM; Prigitano A; Vidal-García M; Marcos-Arias C; Guridi A; Sanchez-Reus F; Machuca-Bárcena J; Rodríguez-Iglesias MA; Martín-Mazuelos E; Castro-Méndez C; López-Soria L; Ruiz-Gaitán A; Fernandez-Rivero M; Lorenzo D; Capilla J; Rezusta A; Pemán J; Guarro J; Pereira J; Pais C; Romeo O; Ezpeleta G; Jauregizar N; Angulo D; Eraso E
Front Cell Infect Microbiol; 2022; 12():906563. PubMed ID: 35651755
[TBL] [Abstract][Full Text] [Related]
6.
Sobel JD; Borroto-Esoda K; Azie N; Angulo D
Antimicrob Agents Chemother; 2021 Jul; 65(8):e0056221. PubMed ID: 34001513
[TBL] [Abstract][Full Text] [Related]
7. Fluconazole-resistant Candida parapsilosis genotypes from hospitals located in five Spanish cities and one in Italy: Description of azole-resistance profiles associated with the Y132F ERG11p substitution.
Mesquida A; Alcoceba E; Padilla E; Ramírez A; Merino P; González-Romo F; De Carolis E; Sanguinetti M; Mantecón-Vallejo MLÁ; Muñoz-Algarra M; Durán-Valle T; Pérez-Ayala A; Gómez-García-de-la-Pedrosa E; Del Carmen Martínez-Jiménez M; Sánchez-Castellano MÁ; Quiles-Melero I; Cuétara MS; Sánchez-García A; Muñoz P; Escribano P; Guinea J;
Mycoses; 2024 Mar; 67(3):e13706. PubMed ID: 38438313
[TBL] [Abstract][Full Text] [Related]
8. Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms.
Sanglard D; Coste AT
Antimicrob Agents Chemother; 2016 Jan; 60(1):229-38. PubMed ID: 26482310
[TBL] [Abstract][Full Text] [Related]
9. Analysis of global antifungal surveillance results reveals predominance of Erg11 Y132F alteration among azole-resistant Candida parapsilosis and Candida tropicalis and country-specific isolate dissemination.
Castanheira M; Deshpande LM; Messer SA; Rhomberg PR; Pfaller MA
Int J Antimicrob Agents; 2020 Jan; 55(1):105799. PubMed ID: 31520783
[TBL] [Abstract][Full Text] [Related]
10. Vulvovaginal candidiasis: species distribution of Candida and their antifungal susceptibility pattern.
Bitew A; Abebaw Y
BMC Womens Health; 2018 Jun; 18(1):94. PubMed ID: 29902998
[TBL] [Abstract][Full Text] [Related]
11. Genotyping and Drug Resistance Profile of Clinical Isolates of Candida albicans from Vulvovaginal Candidiasis in the Eastern China.
Hong N; Lei Y; Chen H; Chen X; Tsui KM; Hu D; Liao W; Yan L; Zhang H; Zhao R; Wu G; Yu N; Deng S
Mycopathologia; 2022 Jun; 187(2-3):217-224. PubMed ID: 35072854
[TBL] [Abstract][Full Text] [Related]
12. ΔF659 and F659S substitutions at the HS1 of FKS2 gene, along with E655A and W715L upstream and downstream substitutions, correlate with high ibrexafungerp MICs against Candidaglabrata.
Mesquida A; Díaz-García J; Sánchez-Carrillo C; Martín-Rabadán P; Alcalá L; Muñoz P; Escribano P; Guinea J
Clin Microbiol Infect; 2022 Aug; 28(8):1154.e5-1154.e8. PubMed ID: 35427779
[TBL] [Abstract][Full Text] [Related]
13. A Novel 1,3-Beta-d-Glucan Inhibitor, Ibrexafungerp (Formerly SCY-078), Shows Potent Activity in the Lower pH Environment of Vulvovaginitis.
Larkin EL; Long L; Isham N; Borroto-Esoda K; Barat S; Angulo D; Wring S; Ghannoum M
Antimicrob Agents Chemother; 2019 May; 63(5):. PubMed ID: 30885896
[TBL] [Abstract][Full Text] [Related]
14. In vitro susceptibility of Candida albicans clinical isolates to eight antifungal agents in Ouagadougou (Burkina Faso).
Zida A; Yacouba A; Bamba S; Sangare I; Sawadogo M; Guiguemde T; Kone S; Traore LK; Ouedraogo-Traore R; Guiguemde RT
J Mycol Med; 2017 Dec; 27(4):469-475. PubMed ID: 28754462
[TBL] [Abstract][Full Text] [Related]
15. Fluconazole-resistant Candida parapsilosis clonally related genotypes: first report proving the presence of endemic isolates harbouring the Y132F ERG11 gene substitution in Spain.
Alcoceba E; Gómez A; Lara-Esbrí P; Oliver A; Beltrán AF; Ayestarán I; Muñoz P; Escribano P; Guinea J
Clin Microbiol Infect; 2022 Aug; 28(8):1113-1119. PubMed ID: 35439634
[TBL] [Abstract][Full Text] [Related]
16. Susceptibility profile of vaginal isolates of Candida albicans prior to and following fluconazole introduction - impact of two decades.
Bulik CC; Sobel JD; Nailor MD
Mycoses; 2011 Jan; 54(1):34-8. PubMed ID: 19563489
[TBL] [Abstract][Full Text] [Related]
17. Correlation between azole susceptibilities, genotypes, and ERG11 mutations in Candida albicans isolates associated with vulvovaginal candidiasis in China.
Ge SH; Wan Z; Li J; Xu J; Li RY; Bai FY
Antimicrob Agents Chemother; 2010 Aug; 54(8):3126-31. PubMed ID: 20516286
[TBL] [Abstract][Full Text] [Related]
18. APX001A
Arendrup MC; Chowdhary A; Astvad KMT; Jørgensen KM
Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30104264
[TBL] [Abstract][Full Text] [Related]
19. Species distribution and antifungal susceptibility profile of Candida isolates from blood and other normally sterile foci from pediatric ICU patients in Tehran, Iran.
Mirhendi H; Charsizadeh A; Eshaghi H; Nikmanesh B; Arendrup MC
Med Mycol; 2020 Feb; 58(2):201-206. PubMed ID: 31111910
[TBL] [Abstract][Full Text] [Related]
20. A multicentre study of antifungal susceptibility patterns among 350 Candida auris isolates (2009-17) in India: role of the ERG11 and FKS1 genes in azole and echinocandin resistance.
Chowdhary A; Prakash A; Sharma C; Kordalewska M; Kumar A; Sarma S; Tarai B; Singh A; Upadhyaya G; Upadhyay S; Yadav P; Singh PK; Khillan V; Sachdeva N; Perlin DS; Meis JF
J Antimicrob Chemother; 2018 Apr; 73(4):891-899. PubMed ID: 29325167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
